San Diego, United States
Allkind, founded in 2022, is making waves in the Health Care industry by addressing a critical issue in the fertility sector. This U.S.-based company is committed to solving the imbalance between the increasing demand for egg donors and surrogates and the availability of qualified, informed candidates.
With their slogan, "Modern Recruitment. Meaningful Impact.", Allkind offers a revolutionary approach by integrating human-first care with scalable systems, data-driven evaluations, and an engaging community model. This ensures candidates remain informed and inspired, fostering a trustworthy pipeline of qualified donors and surrogates.
The company successfully secured a Seed investment on 01 January 2023, backed by Impellent Ventures. This investment underscores belief in Allkind's unique model and its potential to redefine fertility recruitment, making it an appealing opportunity for investors looking to support groundbreaking solutions in healthcare.
